Companies: 10,795·Total market cap: $144.5T
Beta Bionics, Inc.

Beta Bionics, Inc.

BBNXNASDAQHealthcare● Active
$13.87
$-0.02(-0.14%)
Market Cap$618070710
P/E Ratio
52W High$32.71
52W Low$8.8

Beta Bionics, Inc. (BBNX) Revenue

Annual & quarterly revenue history · segment & region breakdown

BBNX · revenue · updated Jun 9, 2026

Core revenue metrics

Beta Bionics, Inc. trailing twelve-month (TTM) revenue is $0.11B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.11B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
5.61×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$313K
352 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Beta Bionics, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
BBNX revenue by year · BBNX revenue history · BBNX annual revenue data

Compare revenue vs peers

Medical - Equipment & Services

Compare BBNX revenue against listed peers. Click any row to open that company's revenue tab.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Beta Bionics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Beta Bionics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Beta Bionics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BBNX revenue · 4 questions

BBNX's trailing twelve-month (TTM) revenue is $0.11B. That is an increase of 0.00% year-over-year from — in FY.

BBNX revenueBBNX annual revenuewhat is BBNX revenueBBNX TTM revenue

Source: FMP · Beta Bionics, Inc. SEC filings · GAAP · Beta Bionics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026